| RS1557768952 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS1557769782 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1557770132 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS1557770154 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Stargardt disease, Stargardt disease |
| RS1557770517 |
VWA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronopathy, distal hereditary motor |
| RS1557772907 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1557773719 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1557776329 |
PPCS
|
Health Risk |
Pathogenic |
Cardiomyopathy, dilated |
| RS1557778273 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS1557778277 |
PPCS
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiomyopathy, dilated |
| RS1557778985 |
GATAD2B
|
Health Risk |
Pathogenic |
Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome, Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome |
| RS1557781252 |
GATAD2B
|
Health Risk |
Pathogenic |
Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome, Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome |
| RS1557783989 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe early-childhood-onset retinal dystrophy, Retinitis pigmentosa 19 |
| RS1557785499 |
ATP1A1
|
Health Risk |
Pathogenic |
Hypomagnesemia, seizures |
| RS1557785503 |
ATP1A1
|
Health Risk |
Pathogenic |
Hypomagnesemia, seizures |
| RS1557787212 |
PADI4
|
Health Risk |
association |
Rheumatoid arthritis, Rheumatoid arthritis |
| RS1557787473 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe early-childhood-onset retinal dystrophy, Stargardt disease |
| RS1557787559 |
ABCA4
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 3, Cone-rod dystrophy 3 |
| RS1557787756 |
ABCA4
|
Health Risk |
Pathogenic |
maculopathy, Severe early-childhood-onset retinal dystrophy |
| RS1557791071 |
COL9A2
|
Health Risk |
Pathogenic |
— |
| RS1557792839 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1557793484 |
COL9A2
|
Health Risk |
Likely pathogenic |
— |
| RS1557794036 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1557794150 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1557794465 |
GDAP2
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia, autosomal recessive 27 |
| RS1557794919 |
DPM3
|
Health Risk |
Pathogenic |
DPM3-congenital disorder of glycosylation, DPM3-congenital disorder of glycosylation |
| RS1557795571 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS1557801639 |
NOTCH2
|
Health Risk |
Pathogenic |
Hajdu-Cheney syndrome, Hajdu-Cheney syndrome |
| RS1557802165 |
NOTCH2
|
Health Risk |
Pathogenic |
Hajdu-Cheney syndrome, Hajdu-Cheney syndrome |
| RS1557802353 |
NOTCH2
|
Health Risk |
Pathogenic |
Hajdu-Cheney syndrome, Hajdu-Cheney syndrome |
| RS1557803353 |
NOTCH2
|
Health Risk |
Pathogenic |
— |
| RS1557804111 |
NOTCH2
|
Health Risk |
Likely pathogenic |
Alagille syndrome due to a NOTCH2 point mutation, Alagille syndrome due to a NOTCH2 point mutation |
| RS1557804884 |
NOTCH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hajdu-Cheney syndrome, NOTCH2-related disorder |
| RS1557806222 |
SKI
|
Health Risk |
Likely pathogenic |
Shprintzen-Goldberg syndrome, Shprintzen-Goldberg syndrome |
| RS1557807153 |
NOTCH2
|
Health Risk |
Pathogenic |
— |
| RS1557810606 |
CLIC4
|
Health Risk |
Likely pathogenic |
Short stature, Short stature |
| RS1557812162 |
NOTCH2
|
Health Risk |
Pathogenic |
Hajdu-Cheney syndrome, Hajdu-Cheney syndrome |
| RS1557812993 |
COL11A1
|
Health Risk |
Pathogenic |
Fibrochondrogenesis, Fibrochondrogenesis |
| RS1557813850 |
SELENON
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myopathy with fiber type disproportion, Eichsfeld type congenital muscular dystrophy |
| RS1557814050 |
SELENON
|
Health Risk |
Pathogenic/Likely pathogenic |
Eichsfeld type congenital muscular dystrophy, Eichsfeld type congenital muscular dystrophy |
| RS1557814066 |
SELENON
|
Health Risk |
Pathogenic |
Eichsfeld type congenital muscular dystrophy, Eichsfeld type congenital muscular dystrophy |
| RS1557814123 |
SPOCD1
|
Health Risk |
Likely pathogenic |
Male infertility with azoospermia or oligozoospermia due to single gene mutation, Male infertility with azoospermia or oligozoospermia due to single gene mutation |
| RS1557814141 |
NOTCH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hajdu-Cheney syndrome, Hajdu-Cheney syndrome |
| RS1557823855 |
CTSK
|
Health Risk |
Pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS1557825245 |
NOTCH2
|
Health Risk |
Likely pathogenic |
— |
| RS1557826721 |
NOTCH2
|
Health Risk |
Likely pathogenic |
— |
| RS1557832711 |
RFX5
|
Health Risk |
Pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS1557836992 |
MUC1
|
Health Risk |
Pathogenic |
— |
| RS1557847904 |
COL11A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Stickler syndrome type 2, Stickler syndrome type 2 |
| RS1557852162 |
CHRNB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS1557852943 |
DARS2
|
Health Risk |
Pathogenic |
Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome, Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome |
| RS1557852998 |
DARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome, Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome |
| RS1557853625 |
DARS2
|
Health Risk |
Likely pathogenic |
Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome, Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome |
| RS1557853666 |
PEX19
|
Health Risk |
Likely pathogenic |
— |
| RS1557853919 |
DENND4B
|
Health Risk |
Likely pathogenic |
Short stature, Short stature |
| RS1557855477 |
DOCK7
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS1557863430 |
POGZ
|
Health Risk |
association |
Autism spectrum disorder, Autism spectrum disorder |
| RS1557863440 |
POGZ
|
Health Risk |
association |
Autism spectrum disorder, Autism spectrum disorder |
| RS1557863546 |
POGZ
|
Health Risk |
association |
Autism spectrum disorder, Autism spectrum disorder |
| RS1557863734 |
ADAR
|
Health Risk |
Pathogenic |
Symmetrical dyschromatosis of extremities, Aicardi-Goutieres syndrome 6 |
| RS1557864817 |
DOCK7
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS1557865780 |
GPSM2
|
Health Risk |
Pathogenic |
— |
| RS1557865787 |
POGZ
|
Health Risk |
Pathogenic |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS1557866540 |
POGZ
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS1557867134 |
POGZ
|
Health Risk |
Pathogenic |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS1557867853 |
POGZ
|
Health Risk |
association |
Autism spectrum disorder, Autism spectrum disorder |
| RS1557868211 |
COPA
|
Health Risk |
Pathogenic |
Autoimmune interstitial lung disease-arthritis syndrome, Autoimmune interstitial lung disease-arthritis syndrome |
| RS1557870645 |
POGZ
|
Health Risk |
association |
Autism spectrum disorder, Autism spectrum disorder |
| RS1557873824 |
POGZ
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1557874046 |
POGZ
|
Health Risk |
association |
Autism spectrum disorder, Autism spectrum disorder |
| RS1557877041 |
COL11A1
|
Health Risk |
Likely pathogenic |
Stickler syndrome type 2, Stickler syndrome type 2 |
| RS1557878687 |
POGZ
|
Health Risk |
Likely pathogenic |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS1557880019 |
NPHP4
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS1557880662 |
FLG
|
Health Risk |
Pathogenic |
— |
| RS1557889974 |
GNB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 42 |
| RS1557891760 |
COL11A1
|
Health Risk |
Likely pathogenic |
— |
| RS1557894839 |
SLC19A2
|
Health Risk |
Pathogenic |
Megaloblastic anemia, thiamine-responsive |
| RS1557895416 |
PLA2G4A
|
Health Risk |
Pathogenic |
Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder, Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder |
| RS1557895715 |
NPHP4
|
Health Risk |
Likely pathogenic |
Nephronophthisis, Nephronophthisis |
| RS1557898800 |
GNB1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 42 |
| RS1557901051 |
POGZ
|
Health Risk |
Pathogenic |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome, Inborn genetic diseases |
| RS1557901325 |
GBA1
|
Health Risk |
Pathogenic |
Gaucher disease, Gaucher disease |
| RS1557901347 |
POGZ
|
Health Risk |
association |
Autism spectrum disorder, Autism spectrum disorder |
| RS1557901552 |
GBA1;LOC106627981
|
Health Risk |
Pathogenic |
Parkinson disease, late-onset |
| RS1557901999 |
PLA2G4A
|
Health Risk |
Pathogenic |
Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder, Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder |
| RS1557902023 |
POGZ
|
Health Risk |
association |
Autism spectrum disorder, Autism spectrum disorder |
| RS1557904209 |
SERPINC1
|
Health Risk |
Likely pathogenic |
— |
| RS1557909170 |
POGZ
|
Health Risk |
Pathogenic |
— |
| RS1557909572 |
POGZ
|
Health Risk |
association |
Autism spectrum disorder, Autism spectrum disorder |
| RS1557909777 |
POGZ
|
Health Risk |
Likely pathogenic |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS1557909821 |
POGZ
|
Health Risk |
association |
Autism spectrum disorder, Autism spectrum disorder |
| RS1557910161 |
PEX10
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder 6A (Zellweger) |
| RS1557910202 |
PEX10
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder 6A (Zellweger), Peroxisome biogenesis disorder |
| RS1557910651 |
PEX10
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder 6A (Zellweger), Peroxisome biogenesis disorder |
| RS1557910728 |
POGZ
|
Health Risk |
association |
Autism spectrum disorder, Autism spectrum disorder |
| RS1557910873 |
POGZ
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS1557911386 |
POGZ
|
Health Risk |
association |
Autism spectrum disorder, Autism spectrum disorder |
| RS1557914199 |
LRIG2
|
Health Risk |
Likely pathogenic |
— |
| RS1557915380 |
F5
|
Health Risk |
Pathogenic |
Congenital factor V deficiency, Congenital factor V deficiency |
| RS1557916296 |
POGZ
|
Health Risk |
association |
Autism spectrum disorder, Autism spectrum disorder |